Cyctek Sheng Yang Yi Wei Granule
Natural health product licensed in Canada
- Other names
- Sheng Yang Yi Wei Combination, Sheng Yang Yi Wei Granule
- Licence holder
- CycTek Inc.
- NPN or DIN-HM
- 80064341
- Status
- Active licence
- Licence date
- 29 September 2015
- Revision date
- Not provided
- Form
- Granules
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
- Conditions légales
Glycyrrhiza uralensis Fisch.: La portion journalière recommandée ne doit pas conduire à une ingestion d'acide glycyrrhizinique supérieure à 100 mg. L'étiquetage doit comporter un avertissement avec la teneur suivante: "Ne pas utiliser pendant plus de 6 semaines sans avis médical." L'étiquetage doit comporter un avertissement déconseillant l'emploi chez les enfants.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Pinellia ternata Source : Rhizome Extract : Matériel brut sec Extraction ratio : 8.603:1 Dry plant equivalent : 499 mg | 58 milligramme | Not calculated |
| Ziziphus jujuba Source : Fruit Extract : Matériel brut sec Extraction ratio : 8.586:1 Dry plant equivalent : 249 mg | 29 milligramme | Not calculated |
| Bupleurum chinense Source : Racine Extract : Matériel brut sec Extraction ratio : 8.588:1 Dry plant equivalent : 146 mg | 17 milligramme | Not calculated |
| Wolfiporia extensa Source : Sclerotium Extract : Matériel brut sec Extraction ratio : 8.588:1 Dry plant equivalent : 146 mg | 17 milligramme | Not calculated |
| Alisma plantago-aquatica subsp. orientale Source : Rhizome Extract : Matériel brut sec Extraction ratio : 8.588:1 Dry plant equivalent : 146 mg | 17 milligramme | Not calculated |
| Angelica pubescens Source : Racine Extract : Matériel brut sec Extraction ratio : 8.586:1 Dry plant equivalent : 249 mg | 29 milligramme | Not calculated |
| Astragalus membranaceus Source : Racine Extract : Matériel brut sec Extraction ratio : 8.603:1 Dry plant equivalent : 998 mg | 116 milligramme | Not calculated |
| Atractylodes macrocephala Source : Rhizome Extract : Matériel brut sec Extraction ratio : 8.588:1 Dry plant equivalent : 146 mg | 17 milligramme | Not calculated |
| Citrus paradisi Source : Pelure (fruit) Extract : Matériel brut sec Extraction ratio : 8.609:1 Dry plant equivalent : 198 mg | 23 milligramme | Not calculated |
| Coptis chinensis Source : Rhizome Extract : Matériel brut sec Extraction ratio : 8.583:1 Dry plant equivalent : 103 mg | 12 milligramme | Not calculated |
| Glycyrrhiza uralensis Source : Rhizome Extract : Matériel brut sec Extraction ratio : 8.603:1 Dry plant equivalent : 499 mg | 58 milligramme | Not calculated |
| Hansenia weberbaueriana Source : Racine et rhizome Extract : Matériel brut sec Extraction ratio : 8.586:1 Dry plant equivalent : 249 mg | 29 milligramme | Not calculated |
| Paeonia lactiflora Source : Racine Extract : Matériel brut sec Extraction ratio : 8.586:1 Dry plant equivalent : 249 mg | 29 milligramme | Not calculated |
| Panax ginseng Source : Racine Extract : Matériel brut sec Extraction ratio : 8.603:1 Dry plant equivalent : 499 mg | 58 milligramme | Not calculated |
| Saposhnikovia divaricata Source : Racine Extract : Matériel brut sec Extraction ratio : 8.586:1 Dry plant equivalent : 249 mg | 29 milligramme | Not calculated |
| Zingiber officinale Source : Rhizome Extract : Matériel brut sec Extraction ratio : 8.603:1 Dry plant equivalent : 499 mg | 58 milligramme | Not calculated |
Non-medicinal ingredients
Amidon de maïs, Stéarate de magnésium, Cellulose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2,000 mg | 3 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Remedy/Product/Preparation based on the theory of Traditional Chinese Medicine.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80064341
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Astragalus membranaceus
Read the warning, when it applies and the studies cited
ASTRAGALUS - ASTRAGALUS MEMBRANACEUS
Route of administration: Oral
Cautions and warnings
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have an autoimmune disorder (Brinker 2010; Upton 1999).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Contraindications
Condition of application: Traditional Chinese Medicine.
Do not use if you have exterior excess, stagnation, yin deficiency or excess heat (Bensky et al. 2004; Chen and Chen 2004).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
- Glycyrrhiza uralensis
Read the warning, when it applies and the studies cited
DEGLYCYRRHIZINATED LICORICE Buccal
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Health Canada monograph dated 31 October 2025
Deglycyrrhizinated Licorice Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Health Canada monograph dated 31 January 2025
LICORICE
Route of administration: Oral
Cautions and warnings
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are breastfeeding (Gardner and McGuffin 2013).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Condition of application: Cough relief.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if cough worsens or persists (for) more than 1 week (EMA 2012).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Condition of application: Gastritis relief.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Contraindications
Condition of application: All products.
Do not use if you are pregnant (EMA 2012).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Do not use if you have hypokalemia, high blood pressure, or a kidney, liver or cardiovascular disorder (EMA 2012; Brinker 2010; ESCOP 2003; Bradley 1992).
4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Do not use if you are taking heart medications, corticosteroids, stimulant laxatives, or other health products that may contribute electrolyte imbalance (Brinker 2010; ESCOP 2003; Hoffmann 2003; Blumenthal et al. 2000).
4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
- Panax ginseng
Read the warning, when it applies and the studies cited
PANAX GINSENG
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have diabetes (Brinker 2010; Vuksan et al. 2008; Seely et al. 2008; Sievenpiper et al. 2006; ESCOP 2003; Tetsutani et al. 2000; Sotaniemi et al. 1995; Chin 1991).
8 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking antidepressant medication, blood thinners or digoxin (Brinker 2010; Lee et al. 2008a; Dasgupta and Reyes 2005; Janetzki and Morreale 1997; Gonzalez-Seijo et al. 1995; Shader and Greenblatt 1988; Jones and Runikis 1987; Shader and Greenblatt 1985).
8 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Contraindications
Condition of application: Traditional Chinese Medicine.
Do not use in cases of yin deficiency with heat signs, heat excess, or in the absence of significant qi deficiency (Bensky et al. 2004).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Known adverse reactions
Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if you experience insomnia, anxiety or headaches (Lee et al. 2008b; Vuksan et al 2008; de Andrade et al.2007; Sievenpiper et al. 2006; Coon and Ernst 2002; Ellis and Reddy 2002; Scaglione et al. 2001; Siegel 1979).
8 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
- Zingiber officinale
Read the warning, when it applies and the studies cited
GINGER - ZINGIBER OFFICINALE
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.